SG

Suresh Gangaram Kawankar

Active Director Director DIN 10806090
DIN 10806090 First appointment Oct 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value •••• Premium profile

About Suresh Gangaram Kawankar

Data last updated:

Suresh Gangaram Kawankar is a Director at Beverly Orthopedic Laboratory Private Limited (since 2024). Beverly Orthopedic Laboratory Private Limited reported revenue of ₹7,112 (FY 2025).

DIN 10806090
Primary Designation Director
First Appointment 11 Oct 2024
Oldest Company Age 2 yrs
Largest company Beverly Orthopedic Laboratory Private Limited · ₹7,112 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Oct 20242024₹7,112 (FY 2025)Active

Board colleagues of Suresh Gangaram Kawankar

Directorship timeline

Open interactive timeline →
Beverly Orthopedic Laboratory Private Limited
Premium access

Shareholding and investment profile for Suresh Gangaram Kawankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Gangaram Kawankar

Suresh Gangaram Kawankar currently holds 1 directorship: Beverly Orthopedic Laboratory Private Limited (Director, since 11 Oct 2024, revenue ₹7,112 (FY 2025)).

Suresh Gangaram Kawankar was first appointed on 11 Oct 2024 as Director at Beverly Orthopedic Laboratory Private Limited.

The current boards of Suresh Gangaram Kawankar's companies include Sachin Suresh Kawankar (Beverly Orthopedic Laboratory Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available